CIK 0000890821 · Non-accelerated filer<br>Smaller reporting company
Enveric Biosciences, Inc.
Sign in to watch- Ticker
- ENVB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 954484725
- Phone
- (617) 444-8400
- Business address
- 245 FIRST STREET RIVERVIEW II 18TH FLOOR, CAMBRIDGE, MA, 02142
- Former names
- AMERI Holdings, Inc., SPATIALIZER AUDIO LABORATORIES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-11-16 | Sikaria Family 2008 Revocable Trust Dated 02/28/2008 10% owner | Sale | −58 | $0.30 | $18 | 2,349,942 |
| 2018-11-16 | Sikaria Family 2008 Revocable Trust Dated 02/28/2008 10% owner | Sale | −1,500 | $0.30 | $452 | 2,348,442 |
| 2018-11-16 | Sikaria Family 2008 Revocable Trust Dated 02/28/2008 10% owner | Sale | −1,515 | $0.30 | $455 | 2,346,927 |
| 2018-11-16 | Sikaria Family 2008 Revocable Trust Dated 02/28/2008 10% owner | Sale | −14,119 | $0.30 | $4K | 2,332,808 |
| 2018-11-16 | Sikaria Family 2008 Revocable Trust Dated 02/28/2008 10% owner | Sale | −15,251 | $0.30 | $5K | 2,317,557 |
| 2018-11-16 | Sikaria Family 2008 Revocable Trust Dated 02/28/2008 10% owner | Sale | −200 | $0.30 | $59 | 2,317,357 |
| 2018-11-16 | Sikaria Family 2008 Revocable Trust Dated 02/28/2008 10% owner | Sale | −6,657 | $0.30 | $2K | 2,310,700 |
| 2018-11-16 | Sikaria Family 2008 Revocable Trust Dated 02/28/2008 10% owner | Sale | −1,850 | $0.29 | $544 | 2,310,700 |
| 2018-11-16 | Sikaria Family 2008 Revocable Trust Dated 02/28/2008 10% owner | Sale | −58,850 | $0.29 | $17K | 2,250,000 |
| 2018-10-17 | Kostiner Barry Chief Financial Officer | Grant or award · Option (Right to Buy) | +150,000 | 150,000 | ||
| 2018-09-12 | Kelton Brent Chief Executive Officer | Grant or award · Option (Right to Buy) | +250,000 | 250,000 | ||
| 2018-09-12 | Patel Viraj J Chief Financial Officer | Grant or award · Option (Right to Buy) | +200,000 | 200,000 | ||
| 2018-08-20 | Angelis Dimitrios Director | Grant or award · Option (Right to Buy) | +35,000 | 35,000 | ||
| 2018-08-20 | Angelis Dimitrios Director | Grant or award · Restricted Stock Unit | +10,000 | 10,000 | ||
| 2018-08-20 | LUCI DAVID P Director | Grant or award · Option (Right to Buy) | +150,000 | 150,000 | ||
| 2018-08-20 | LUCI DAVID P Director | Grant or award · Restricted Stock Unit | +15,000 | 15,000 | ||
| 2018-08-20 | Shawah Robert G. Director | Grant or award · Option (Right to Buy) | +35,000 | 35,000 | ||
| 2018-08-20 | Shawah Robert G. Director | Grant or award · Restricted Stock Unit | +10,000 | 10,000 | ||
| 2018-08-20 | Shad James Director | Grant or award · Option (Right to Buy) | +35,000 | 35,000 | ||
| 2018-08-20 | Shad James Director | Grant or award · Restricted Stock Unit | +10,000 | 10,000 |
Page 6 of 20 · 386 trades